You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis

 

Online download statistics by month:

Online download statistics by month: April 2016 to March 2024

AbstractFullPdf
Apr 2016724721
May 20161903386
Jun 2016973738
Jul 2016935840
Aug 2016622426
Sep 201644727
Oct 2016933718
Nov 2016804912
Dec 2016432215
Jan 2017758
Feb 2017137
Mar 20172227
Apr 201703012
May 20170299
Jun 201722409
Jul 201722229
Aug 201726240
Sep 201719198
Oct 201738364
Nov 2017737110
Dec 2017767611
Jan 20181201229
Feb 201892835
Mar 20181141125
Apr 201851529
May 2018646512
Jun 201832327
Jul 201836368
Aug 201853499
Sep 201841379
Oct 2018525220
Nov 2018858510
Dec 20181271279
Jan 201910310012
Feb 2019827912
Mar 201947439
Apr 2019323112
May 201919198
Jun 201926279
Jul 2019252516
Aug 201919199
Sep 2019161611
Oct 2019333112
Nov 201917165
Dec 201919195
Jan 202023236
Feb 202022225
Mar 202011115
Apr 20201197
May 202013134
Jun 2020171710
Jul 202016144
Aug 2020866
Sep 2020191810
Oct 2020211910
Nov 2020271718
Dec 202011117
Jan 202110108
Feb 202111114
Mar 202120206
Apr 202118185
May 2021192013
Jun 2021161616
Jul 20215510
Aug 2021141416
Sep 2021121211
Oct 2021191725
Nov 20216614
Dec 202119192
Jan 202215169
Feb 202210108
Mar 202210106
Apr 202216184
May 2022313111
Jun 202240405
Jul 202214141
Aug 202223233
Sep 2022272711
Oct 2022151516
Nov 2022231711
Dec 202210109
Jan 2023171916
Feb 202314125
Mar 2023676
Apr 2023887
May 202312108
Jun 2023883
Jul 202313139
Aug 2023665
Sep 202316150
Oct 202316161
Nov 202316144
Dec 202318185
Jan 202420204
Feb 202422226
Mar 2024171746
Total317627521050